StayCurrentMD · Validating the Modified McGill Thyroid Nodule Score for Assessment of Preoperative Risk of Pediatric Thyroid Malignancy
Follow
Article1 min read·Published Mar 2024Older

Validating the Modified McGill Thyroid Nodule Score for Assessment of Preoperative Risk of Pediatric Thyroid Malignancy

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Mar 2024 · 1 min read

In brief

In brief

This validation study evaluates the modified McGill Thyroid Nodule Score (mMTNS) as a preoperative risk assessment tool for predicting thyroid malignancy in pediatric patients with indeterminate fine needle aspiration results. The research aims to confirm earlier pilot findings that the mMTNS can effectively stratify cancer risk in children, adapting an adult-validated scoring system for the pediatric population.

Written by the GCMD Library team from the article.

The McGill Thyroid Nodule Score (MTNS) is a preoperative tool used to predict the risk for well-differentiated thyroid cancer in adults. It was developed by a multidisciplinary team using established evidence-based risk factors for thyroid cancer. The modified McGill Thyroid Nodule Score (mMTNS) was developed to predict malignancy risk in children. A pilot study suggested the mMTNS was able to assess malignancy risk in children with indeterminate cytology on fine needle aspiration (FNA). This study seeks to validate these findings.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →